EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE

Scope & Guideline

Exploring the Frontiers of Microbial and Immune Research

Introduction

Explore the comprehensive scope of EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE in depth and align your research initiatives with current academic trends.
LanguageCzech
ISSN1210-7913
PublisherCESKA LEKARSKA SPOLECNOST J EV PURKYNE
Support Open AccessNo
CountryCzech Republic
TypeJournal
Convergefrom 1994 to 2024
AbbreviationEPIDEMIOL MIKROBI IM / Epidemiol. Mikrobiol. Imunol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSOKOLSKA 31, PRAGUE 00000, CZECH REPUBLIC

Aims and Scopes

The journal "EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE" primarily focuses on the interplay of infectious diseases, microbiology, and immunology within a public health context. It aims to disseminate research findings that enhance the understanding and management of infectious diseases through epidemiological studies, molecular microbiology, and immunological insights.
  1. Epidemiological Studies:
    The journal emphasizes the importance of epidemiological research, including surveillance and analysis of disease outbreaks, trends in infection rates, and risk factors associated with various infectious diseases.
  2. Microbial Pathogenesis:
    Research on the mechanisms by which pathogens cause disease is a core focus, including studies on specific bacteria, viruses, and their interactions with human hosts.
  3. Immunological Responses:
    The journal covers studies that explore immune responses to infections, including vaccine efficacy, antibody production, and immune evasion strategies employed by pathogens.
  4. Molecular Microbiology:
    Whole genome sequencing and molecular characterization of pathogens are highlighted, showcasing advances in diagnostic techniques and understanding genetic diversity among microbial strains.
  5. Public Health and Preventive Medicine:
    There is a consistent focus on public health implications of infectious diseases, including prevention strategies, vaccination campaigns, and health behavior studies.
The journal has been adapting to emerging public health challenges and scientific advancements, resulting in several trending themes that reflect current priorities in infectious disease research.
  1. COVID-19 Research:
    Significant attention is being given to SARS-CoV-2 and its variants, focusing on epidemiological trends, vaccination responses, and the long-term impacts of the pandemic on public health.
  2. Whole Genome Sequencing Applications:
    There is a growing trend towards the application of whole genome sequencing in understanding microbial diversity, resistance mechanisms, and tracking outbreaks, indicating a shift towards precision medicine.
  3. Impact of Climate on Infectious Diseases:
    Emerging studies are increasingly exploring the relationship between climate change and the dynamics of infectious diseases, particularly vector-borne illnesses, which is critical for future public health preparedness.
  4. Microbiome Research:
    Research on the human microbiome and its implications for health and disease is gaining traction, highlighting its role in immune responses and disease susceptibility.
  5. Health Behavior and Risk Analysis:
    Emerging themes focus on the behaviors and risk factors associated with infectious diseases, particularly among specific populations, such as university students, which is crucial for targeted public health interventions.

Declining or Waning

While the journal maintains a broad focus on infectious diseases and related fields, certain themes appear to be declining in prominence as reflected in recent publications.
  1. Traditional Infectious Disease Management:
    There is a noticeable reduction in studies focused on conventional approaches to managing infectious diseases, such as standard treatment protocols, which may be overshadowed by emerging research on molecular and immunological aspects.
  2. Non-infectious Disease Studies:
    Research articles that previously addressed chronic non-infectious diseases or conditions indirectly related to infectious diseases seem to be less frequent, indicating a shift toward a more focused infectious disease perspective.
  3. Historical Epidemiological Data:
    While historical data remains important, there seems to be a waning interest in retrospective studies that do not incorporate new methodologies or technologies, such as genomic analysis.

Similar Journals

MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Unveiling groundbreaking research in medical microbiology and immunology.
Publisher: SPRINGERISSN: 0300-8584Frequency: 6 issues/year

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.

Virulence

Pioneering Research for Healthier Futures
Publisher: TAYLOR & FRANCIS INCISSN: 2150-5594Frequency: 8 issues/year

Virulence, a leading academic journal published by Taylor & Francis Inc, is dedicated to advancing the understanding of virulence mechanisms in pathogens across various infectious diseases. Since becoming an Open Access publication in 2018, it has broadened the accessibility of cutting-edge research for a global audience, promoting collaboration and knowledge-sharing among researchers, professionals, and students alike. With a significant impact within its field, the journal boasts impressive 2023 quartile rankings: Q2 in Immunology and Q1 in both Infectious Diseases and Microbiology, alongside notable standings in Parasitology. The current Scopus rankings reinforce its prominence, with high percentiles indicating its influence and relevance in advancing scientific inquiry. Covering a period from 2010 to 2024, Virulence serves as an essential platform for innovative research that not only addresses the critical challenges in understanding pathogen behavior but also contributes towards global health solutions, establishing it as a vital resource in the rapidly evolving fields of immunology, microbiology, and parasitology.

Indian Journal of Medical Microbiology

Your Gateway to Open Access Microbiological Research
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

JOURNAL OF INFECTIOUS DISEASES

Connecting Research to Practice in Infectious Disease Care
Publisher: OXFORD UNIV PRESS INCISSN: 0022-1899Frequency: 24 issues/year

The JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.

INFECTION AND IMMUNITY

Empowering Researchers with Cutting-Edge Discoveries
Publisher: AMER SOC MICROBIOLOGYISSN: 0019-9567Frequency: 12 issues/year

INFECTION AND IMMUNITY is a distinguished peer-reviewed journal published by the American Society for Microbiology, focusing on groundbreaking research in the fields of infection, immunology, microbiology, and parasitology. Established in 1971, this journal has built a robust legacy, converging years of scientific discovery with a vision towards 2024 and beyond. With an impressive Impact Factor, the journal holds significant rankings in various categories; its Q1 status in both Infectious Diseases and Parasitology underscores its high relevance and quality within the scientific community. Researchers and professionals alike will benefit from its content, as it promotes the latest advances in understanding immune responses and infectious agents, further legitimizing its place among the top quartiles of its respective fields. Access options are provided through traditional subscription models, ensuring a broad charitable dissemination of knowledge. As a pivotal resource for scholars and practitioners alike, INFECTION AND IMMUNITY stands at the forefront of microbiological and immunological research, fostering essential discourse that is crucial for advancing public health and scientific insight.

Infektsiya i Immunitet

Advancing knowledge in immunology and infectious diseases.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Innovating research for a healthier tomorrow.
Publisher: AKADEMIAI KIADO ZRTISSN: 1217-8950Frequency: 4 issues/year

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

Reviews and Research in Medical Microbiology

Delivering High-Impact Research for Healthcare Professionals
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2770-3150Frequency: 4 issues/year

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

Tuberculosis

Advancing knowledge in the fight against tuberculosis.
Publisher: CHURCHILL LIVINGSTONEISSN: 1472-9792Frequency: 6 issues/year

Tuberculosis is an esteemed peer-reviewed journal specializing in the fields of Infectious Diseases, Immunology, and Microbiology, published by Churchill Livingstone since 1974. With a scope aimed at advancing the understanding and management of tuberculosis and related infectious diseases, the journal provides a platform for innovative research findings, clinical practices, and policy discussions. It is ranked in the Q2 category for both Infectious Diseases and Microbiology (medical), reflecting its significance in the academic community and the impact of its published work. The journal's commitment to openness is evident in its access options, fostering wider dissemination of knowledge. With an impact factor that underscores its relevance, Tuberculosis serves as a crucial resource for researchers, healthcare professionals, and students dedicated to combatting these pressing health challenges. The journal operates from its production headquarters in Edinburgh, Scotland, ensuring a strong connection to the international research community.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Elevating the discourse on infectious disease science.
Publisher: ELSEVIER SCI LTDISSN: 1201-9712Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.